SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-015804
Filing Date
2019-08-14
Accepted
2019-08-14 16:13:09
Documents
41
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0619_hoththerapeutics.htm 10-Q 394273
2 CERTIFICATION f10q0619ex31-1_hoth.htm EX-31.1 15412
3 CERTIFICATION f10q0619ex31-2_hoth.htm EX-31.2 15532
4 CERTIFICATION f10q0619ex32-1_hoth.htm EX-32.1 5379
5 CERTIFICATION f10q0619ex32-2_hoth.htm EX-32.2 5265
  Complete submission text file 0001213900-19-015804.txt   1987532

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE hoth-20190630.xml EX-101.INS 267195
7 XBRL SCHEMA FILE hoth-20190630.xsd EX-101.SCH 30236
8 XBRL CALCULATION FILE hoth-20190630_cal.xml EX-101.CAL 29236
9 XBRL DEFINITION FILE hoth-20190630_def.xml EX-101.DEF 106454
10 XBRL LABEL FILE hoth-20190630_lab.xml EX-101.LAB 204279
11 XBRL PRESENTATION FILE hoth-20190630_pre.xml EX-101.PRE 151187
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38803 | Film No.: 191026498
SIC: 2834 Pharmaceutical Preparations